{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:03:05Z","timestamp":1793109785050,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012268","name":"Proteomass Scientific Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"REQUIMTE LAQV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bioorg.2021.105470","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T10:59:19Z","timestamp":1636369159000},"page":"105470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica\u2013based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections"],"prefix":"10.1016","volume":"118","author":[{"given":"Joana","family":"Galhano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gon\u00e7alo A.","family":"Marcelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paula","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105470_b0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/ijms20061255","article-title":"Thinking Outside the Bug: Molecular Targets and Strategies to Overcome Antibiotic Resistance","volume":"20","author":"Monserrat-Martinez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.105470_b0010","doi-asserted-by":"crossref","unstructured":"S. Bin Zaman, M.A. Hussain, R. Nye, V. Mehta, K.T. Mamun, N. Hossain, A Review on Antibiotic Resistance: Alarm Bells are Ringing, Cureus 9 (2017) 1403. doi:10.7759\/cureus.1403.","DOI":"10.7759\/cureus.1403"},{"key":"10.1016\/j.bioorg.2021.105470_b0015","unstructured":"Antibiotic resistance. Accessed February28, 2021., (2021). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105470_b0020","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1586\/14787210.2014.920253","article-title":"Antibiotic resistance in cancer patients","volume":"12","author":"Gudiol","year":"2014","journal-title":"Expert Rev. Anti. Infect. Ther."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105470_b0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jmv.25750","article-title":"Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis","volume":"92","author":"Fang","year":"2020","journal-title":"J. Med. Virol."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105470_b0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105470_b0035","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream Infections by Extended-Spectrum \u03b2-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Children: Epidemiology and Clinical Outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105470_b0040","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105470_b0045","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105470_b0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105470_b0055","first-page":"2371","article-title":"Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia","volume":"20","author":"Kang","year":"2012","journal-title":"Support. Care Cancer."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105470_b0060","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1634\/theoncologist.2012-0029","article-title":"Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center","volume":"17","author":"Mahajan","year":"2012","journal-title":"Oncologist."},{"key":"10.1016\/j.bioorg.2021.105470_b0065","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/archinte.162.19.2223","article-title":"Health and Economic Outcomes of Vancomycin-Resistant Enterococci","volume":"162","author":"Carmeli","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105470_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41579-020-00469-5","article-title":"Nanomaterials arising amid antibiotic resistance","volume":"19","author":"Gao","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2021.105470_b0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jfb11040084","article-title":"Silver Nanoparticles: Mechanism of Action and Probable Bio-Application","volume":"11","author":"Mikhailova","year":"2020","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.bioorg.2021.105470_b0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fchem.2018.00554","article-title":"Engineered Nanostructured Materials for Ofloxacin Delivery","volume":"6","author":"Nuti","year":"2018","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105470_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijvsm.2017.02.003","article-title":"Antibacterial effect of gold nanoparticles against Corynebacterium pseudotuberculosis","volume":"5","author":"Mohamed","year":"2017","journal-title":"Int. J. Vet. Sci. Med."},{"key":"10.1016\/j.bioorg.2021.105470_b0090","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s42452-020-3023-6","article-title":"Gold@mesoporous silica nanocarriers for the effective delivery of antibiotics and by-passing of \u03b2-lactam resistance","volume":"2","author":"Marcelo","year":"2020","journal-title":"SN Appl. Sci."},{"issue":"19","key":"10.1016\/j.bioorg.2021.105470_b0095","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/smll.201200575","article-title":"Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms","volume":"8","author":"Taylor","year":"2012","journal-title":"Small."},{"key":"10.1016\/j.bioorg.2021.105470_b0100","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fphar.2019.01153","article-title":"Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms","volume":"10","author":"Lee","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105470_b0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41565-017-0013-y","article-title":"Bacterial resistance to silver nanoparticles and how to overcome it","volume":"13","author":"Pan\u00e1\u010dek","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioorg.2021.105470_b0110","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.2147\/IJN.S132163","article-title":"Nanomaterials for alternative antibacterial therapy","volume":"12","author":"Hemeg","year":"2017","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.bioorg.2021.105470_b0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/molecules21010026","article-title":"Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic Effect","volume":"21","author":"Pan\u00e1\u010dek","year":"2015","journal-title":"Molecules."},{"issue":"23","key":"10.1016\/j.bioorg.2021.105470_b0120","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/nnm-2017-0273","article-title":"Are antibiotic-functionalized nanoparticles a promising tool in antimicrobial therapies?","volume":"12","author":"de Oliveira","year":"2017","journal-title":"Nanomedicine."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105470_b0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/thno.8263","article-title":"Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics","volume":"4","author":"Shen","year":"2014","journal-title":"Theranostics."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105470_b0130","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.1021\/nn4035316","article-title":"High Capacity Nanoporous Silicon Carrier for Systemic Delivery of Gene Silencing Therapeutics","volume":"7","author":"Shen","year":"2013","journal-title":"ACS Nano."},{"key":"10.1016\/j.bioorg.2021.105470_b0135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.actbio.2020.08.032","article-title":"Dual antibacterial drug-loaded nanoparticles synergistically improve treatment of Streptococcus mutans biofilms","volume":"115","author":"Sims","year":"2020","journal-title":"Acta Biomater."},{"issue":"7614","key":"10.1016\/j.bioorg.2021.105470_b0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature18930","article-title":"Synchronized cycles of bacterial lysis for in vivo delivery","volume":"536","author":"Din","year":"2016","journal-title":"Nature."},{"key":"10.1016\/j.bioorg.2021.105470_b0145","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ma11081310","article-title":"Toxicological Evaluation of Luminescent Silica Nanoparticles as New Drug Nanocarriers in Different Cancer Cell Lines","volume":"11","author":"Marcelo","year":"2018","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.bioorg.2021.105470_b0150","unstructured":"Escherichia coli (Migula) Castellani and Chalmers ATCC \u00ae 8739&trad, n.d. https:\/\/www.lgcstandards-atcc.org\/products\/all\/8739.aspx?geo_country=pt#general information."},{"key":"10.1016\/j.bioorg.2021.105470_b0155","unstructured":"Staphylococcus aureus subsp. aureus Rosenbach ATCC \u00ae 6538TM, n.d. https:\/\/www.lgcstandards-atcc.org\/Products\/All\/6538?geo_country=pt#."},{"key":"10.1016\/j.bioorg.2021.105470_b0160","unstructured":"Staphylococcus aureus subsp. aureus Rosenbach | ATCC, n.d. https:\/\/www.atcc.org\/products\/33591."},{"key":"10.1016\/j.bioorg.2021.105470_b0165","unstructured":"Enterococcus faecalis (Andrewes and Horder) Schleifer and Kilpper-Balz., n.d. https:\/\/www.lgcstandards-atcc.org\/Products\/All\/29212?geo_country=pt."},{"key":"10.1016\/j.bioorg.2021.105470_b0170","unstructured":"Pseudomonas aeruginosa (Schroeter) Migula ATCC \u00ae 9027TM, n.d. https:\/\/www.lgcstandards-atcc.org\/products\/all\/9027.aspx?geo_country=pt."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105470_b0175","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/cm030633n","article-title":"A Fast and Efficient Ion-Exchange Procedure To Remove Surfactant Molecules from MCM-41 Materials","volume":"16","author":"Lang","year":"2004","journal-title":"Chem. Mater."},{"key":"10.1016\/j.bioorg.2021.105470_b0180","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1039\/b925137e","article-title":"Fabrication of mesoporous silica-coated CNTs and application in size-selective protein separation","volume":"20","author":"Zhang","year":"2010","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.bioorg.2021.105470_b0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.dyepig.2018.09.047","article-title":"Sustainable synthesis of luminescent CdTe quantum dots coated with modified silica mesoporous nanoparticles: Towards new protein scavengers and smart drug delivery carriers","volume":"161","author":"Oliveira","year":"2019","journal-title":"Dye. Pigment."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105470_b0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2710.1990.tb00387.x","article-title":"Photodegradation of Doxorubicin, Daunorubicin and Epirubicin measured by High-Performance Liquid Chromatography","volume":"15","author":"Wood","year":"1990","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bioorg.2021.105470_b0195","doi-asserted-by":"crossref","first-page":"117569","DOI":"10.1016\/j.saa.2019.117569","article-title":"Assessing physical properties of amphoteric fluoroquinolones using phosphorescence spectroscopy, Spectrochim","volume":"227","author":"Soldevila","year":"2020","journal-title":"Acta Part A Mol. Biomol. Spectrosc."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105470_b0200","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2165\/00003495-199345050-00011","article-title":"Epirubicin","volume":"45","author":"Plosker","year":"1993","journal-title":"Drugs."},{"key":"10.1016\/j.bioorg.2021.105470_b0205","doi-asserted-by":"crossref","unstructured":"F. Arcamone, G. Cassinelli, G. Franceschi, S. Penco, C. Pol, S. Redaelli, A. Selva, Structure and Physicochemical Properties of Adriamycin (Doxorubicin), in: Int. Symp. Adriamycin, Springer Berlin Heidelberg, Berlin, Heidelberg (1972) 9\u201322. doi:10.1007\/978-3-642-95227-2_2.","DOI":"10.1007\/978-3-642-95227-2_2"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105470_b0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0305-7372(93)90036-Q","article-title":"Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity","volume":"19","author":"Paul Launchbury","year":"1993","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2021.105470_b0215","doi-asserted-by":"crossref","first-page":"034703","DOI":"10.1063\/1.5138912","article-title":"Control of interfacial pH in mesoporous silica nanoparticles via surface functionalization","volume":"152","author":"Singappuli-Arachchige","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105470_b0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/BF02111343","article-title":"Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin","volume":"13","author":"Barry","year":"1994","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105470_b0225","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/jcm.27.1.49-52.1989","article-title":"Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria","volume":"27","author":"Fuchs","year":"1989","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105470_b0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-8579(01)00356-9","article-title":"Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants","volume":"18","author":"Fung-Tomc","year":"2001","journal-title":"Int. J. Antimicrob. Agents."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105470_b0235","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/ar3000986","article-title":"Mesoporous Silica Nanoparticle Nanocarriers: Biofunctionality and Biocompatibility","volume":"46","author":"Tarn","year":"2013","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105470_b0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/bies.20160","article-title":"The anthracycline antibiotics: antitumor drugs that alter chromatin structure","volume":"27","author":"Rabbani","year":"2005","journal-title":"BioEssays."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105470_b0245","first-page":"687","article-title":"Antimicrobial activities of daunorubicin and adriamycin derivatives on bacterial and protoplast type L-from cells ofBacillus subtilis 170, Escherichia coli B, andProteus mirabilis VI. Structure \u2014 activity relationship","volume":"22","author":"Gumpert","year":"1982","journal-title":"Z. Allg. Mikrobiol."},{"key":"10.1016\/j.bioorg.2021.105470_b0250","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3389\/fmicb.2019.01556","article-title":"Repurposed Antimicrobial Combination Therapy: Tobramycin-Ciprofloxacin Hybrid Augments Activity of the Anticancer Drug Mitomycin C Against Multidrug-Resistant Gram-Negative Bacteria","volume":"10","author":"Domalaon","year":"2019","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105470_b0255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4161\/viru.21282","article-title":"Intrinsic and acquired resistance mechanisms in enterococcus","volume":"3","author":"Hollenbeck","year":"2012","journal-title":"Virulence."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:22:42Z","timestamp":1758615762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821008488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":51,"alternative-id":["S0045206821008488"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105470","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica\u2013based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105470"}}